Sermorelin Peptide

GHRH(1-29) analog, the shortest fully functional fragment of growth hormone releasing hormone. 29 amino acid peptide for receptor studies.

Login to view pricing and purchase

Create a free account to see prices, select variants, and place orders.

Log In / Create Account

Quick Facts

SKUACR-SERM
CAS Number86168-78-7
Molecular Weight3357.88 g/mol
SequenceGHRH(1-29)-NH2
Purity≥98%
Physical FormLyophilized Powder
StorageStore at -20°C

What is Sermorelin?

Sermorelin (Sermorelin Acetate) is a synthetic 29-amino acid peptide corresponding to the first 29 amino acids of the 44-amino acid native GHRH (growth hormone releasing hormone). This N-terminal fragment retains the full biological activity of GHRH, as the first 29 residues contain the complete receptor-binding domain. Sermorelin was the first GHRH analog approved for diagnostic and research use. It activates the GHRH receptor on anterior pituitary somatotroph cells, stimulating endogenous GH synthesis and secretion in a physiological pulsatile pattern. For laboratory research use only.

Frequently Asked Questions

What is Sermorelin?

Sermorelin is a synthetic 29-amino acid peptide representing the biologically active N-terminal fragment of GHRH. It activates the GHRH receptor to stimulate endogenous GH production. For research use only.

How does Sermorelin compare to CJC-1295?

Both activate the GHRH receptor, but CJC-1295 has four amino acid substitutions that improve metabolic stability. Sermorelin is more rapidly degraded by DPP-IV enzymes, resulting in a shorter half-life. CJC-1295 was designed specifically to overcome this limitation.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.